ArticleFrontiers in immunology2017

Tocilizumab Contributes to the Inflammatory Status of Mature Dendritic Cells through Interleukin-6 Receptor Subunits Modulation.

Daniel Meley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.